Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TK-90 for Radiation-Induced Mucositis in Head and Neck Cancer
NCT05658016Phase 2Unknown
- Sponsor
- Tosk, Inc.
- Start
- Jun 2022
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TK-112690 in mucositis, sponsored by Tosk, Inc.. Status: unknown.
02
Drugs
TK-112690
03
Conditions
mucositis
Beyond the preview
Go deeper on NCT05658016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05658016.